AVL
Direxion Daily AVGO Bull 2X Shares
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
19.29% more ownership
Funds ownership: 0% [Q3] → 19.29% (+19.29%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for AVL.
Financial journalist opinion
Positive
ETF Trends
2 months ago
Broadcom Looks to Build Off Last Year's Strength
The artificial intelligence (AI) theme dominated in 2024. One of the beneficiaries was Broadcom.
Neutral
Business Wire
2 months ago
AV Laboratories Debuts Two New Groundbreaking Skin Care Solutions to Transform Beauty Routines
NEW YORK--(BUSINESS WIRE)--AV Laboratories (AVL), a luxury skin longevity brand that represents the apex in science-backed, age-defying skin care today announced the launch of Face Cream Rich and Eye Cream. As the latest additions to the brand's portfolio, these products complement AV Laboratories' Essentials Duo, Face Serum and Face Cream Light. The new products offer enhanced routine customization with creams that deliver unmatched nourishment, moisture, hydration and wellness to your skin, j.
Positive
Zacks Investment Research
4 months ago
4 Best Leveraged ETFs of Last Week
Wall Street delivered mixed performance last week.
Positive
ETF Trends
6 months ago
Direxion Expands Semiconductor Library With 4 New Funds
On Thursday, Direxion launched four new leveraged and inverse ETFs that bring single-stock exposure to the semiconductor sector. The Direxion Daily AVGO Bull 2X Shares (AVL) and the Direxion Daily AVGO Bear 1X Shares (AVS) focus on Broadcom.
Charts implemented using Lightweight Charts™